Image Image Image Image Image Image Image Image Image Image
Accessibilité
Haut de page

Up

AG_assaigCHROMA

· 29/01/2015

CHROMA: Clinical Trial of Lampalizumab for Geographic Atrophy Secondary to Age-Related Macular Degeneration

Injeccions

· 19/12/2014

FOVISTA NR: Clinical Trial for neovascular age-related macular degeneration

Lite 1

· 21/12/2014

LITE: Development of Advanced Laser Imaging Techniques for the anterior and posterior Eye

Foto2

· 01/01/2015

FOVISTA: Clinical Trial for subfoveal neovascular age-related macular degeneration

DMAE atrofica

· 19/03/2014

Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD

Foto4_def

· 31/03/2014

Phase III Study of Lampalizumab in patients with geographic atrophy secondary to AMD

Foto44_3

· 20/12/2014

MPL4 GA: A phase I study in subjects with geographic atrophy secondary to dry age-related macular degeneration  

Foto49_3

· 20/12/2014

Oral Omega 3 GA. A phase II in subjects with geographic atrophy secondary to AMD

color nvc

· 16/01/2015

A delphi study to detect deficiencies and propose actions in real life treatment of neovascular age-related macular degeneration.

RD edema macular

· 21/12/2014

Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.

_MG_8226

· 23/12/2014

Ranibizumab in retinal vein occlusion: treatment recommendations by an expert panel.

Injeccions (2)

· 23/12/2014

Effect of pegaptanib sodium 0.3 mg intravitreal injections (Macugen) in intraocular pressure: posthoc analysis from V.I.S.I.O.N. study.

LatentClass1

· 20/11/2014

Reappraisal of geographic atrophy patterns seen on fundus autofluorescence using a latent class analysis approach.

Glaucoma_Nervioptic1_PORTADA

· 02/07/2014

Prospective, randomised, placebo-controlled, double-masked, three-armed, multicenter Phase II/III trial to establish the safety and efficacy of a topical treatment of Neovascular Glaucoma

Traccio macular

· 02/07/2014

JETREA M-13-056 Assessment of anatomical and functional outcomes in patients treated with ocriplasmin for vitreomacular traction/symptomatic vitreomacular adhesion

Last modified: 10 January, 2023 - 11:23


Open chat